CBE Colloquia - Biomedical Sensors for Precision Diagnostics
Supporting the below United Nations Sustainable Development Goals:支持以下聯合國可持續發展目標：支持以下联合国可持续发展目标：
Real-time sensing technologies utilizing colorimetric, fluorescent, and photonic crystal biosensors are poised to revolutionize the next generation of clinical and point-of-care applications, including in vitro diagnostics, wearable devices, and implantable technologies. In this talk, Dr. Yetisen will explore recent advances in the development of real-time photonic biochemical sensors that provide quantitative insights into clinically relevant biomarkers. He will present findings from pilot clinical studies, highlighting the potential impact of these biosensors on healthcare. The talk will also cover smartphone-based spectrophotometer platforms designed to enable low-cost point-of-care medical technologies. Additionally, attendees will gain valuable knowledge about the commercialization of biosensors and medical devices, with an emphasis on innovative startup companies.
Dr. Yetisen is an Associate Professor and Senior Lecturer in the Department of Chemical Engineering at Imperial College London. He holds a Ph.D. in Chemical Engineering (Biotechnology) from the University of Cambridge. He has worked as a Tosteson Fellow at Harvard University and Massachusetts General Hospital. Dr. Yetisen has received numerous international awards, including the IChemE Nicklin Medal, the Birmingham Fellowship, and the Alexander von Humboldt Fellowship. He is a Fellow of the Royal Society of Chemistry, the Institute of Physics, the Institution of Chemical Engineers, and the Institution of Engineering and Technology. Additionally, he serves as an Associate Editor for the journals Sensors & Diagnostics (RSC) and Aggregate (Wiley).